Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.

Sato N, Lam CS, Teerlink JR, Greenberg BH, Tsutsui H, Oh BH, Zhang J, Lefkowitz M, Hua TA, Holbro T, Marshood M, Wang XL, Ge J.

J Card Fail. 2017 Jan;23(1):63-71. doi: 10.1016/j.cardfail.2016.10.016. Epub 2016 Nov 4.

2.
3.

ErbB receptors: directing key signaling networks throughout life.

Holbro T, Hynes NE.

Annu Rev Pharmacol Toxicol. 2004;44:195-217. Review.

PMID:
14744244
4.

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.

Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas CF 3rd, Hynes NE.

Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8933-8. Epub 2003 Jul 9.

5.

The ErbB receptors and their role in cancer progression.

Holbro T, Civenni G, Hynes NE.

Exp Cell Res. 2003 Mar 10;284(1):99-110. Review.

PMID:
12648469
6.

Wnt1 and Wnt5a induce cyclin D1 expression through ErbB1 transactivation in HC11 mammary epithelial cells.

Civenni G, Holbro T, Hynes NE.

EMBO Rep. 2003 Feb;4(2):166-71. Erratum in: EMBO Rep. 2003 Mar;4(3):326.

8.

Molecular interaction between human tumor marker protein p150, the largest subunit of eIF3, and intermediate filament protein K7.

Lin L, Holbro T, Alonso G, Gerosa D, Burger MM.

J Cell Biochem. 2001;80(4):483-90.

PMID:
11169732

Supplemental Content

Loading ...
Support Center